Clinically, thrombocytopenia was found in some patients treated with Cox-2 inhibitors, which is also consistent with our study and may provide some theoretical possibilities for us to study the treatment of ITP. Here, PTGS2 is linked to autoimmune thrombocytopenic purpura.